Approximately two decades ago, Robert Schreibers team discovered that IFNγ and lymphocytes not only protect the host against tumor growth by upregulating MHC class I but also function to select for tumor variants with lower immunogenicity, which can more easily evade immunosurveillance (Shankaran et al, 2001). Here, IFNG is linked to neoplasm.